This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Nucleus Therapeutics Pty. Ltd, Yale University. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 1,368 
Years Active: 2023-2025
Title: Innovations by James Campbell
Introduction
James Campbell is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of binding proteins. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
One of his latest patents is titled "Binding Proteins 1." This patent relates to cell-penetrating anti-DNA binding proteins. The compositions comprising these binding proteins may be useful for delivering agents to cells and treating diseases such as cancer. This innovative approach has the potential to revolutionize treatment methodologies in oncology.
Career Highlights
Throughout his career, James Campbell has worked with esteemed organizations such as Nucleus Therapeutics Pty. Ltd and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Valentina Dubljevic and James E. Hansen. Their collaborative efforts have further advanced the research and development of binding proteins.
Conclusion
James Campbell's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile